Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.

Abstract

BACKGROUND Antibody-mediated rejection (AMR) is responsible for a large proportion of early allograft losses. While preformed donor-specific human leukocyte antigen (HLA)-antibodies (HLA-DSA) are accountable for the majority of these episodes, non-HLA-DSA are also involved. However, data on the incidence of early AMR due to non-HLA-DSA are currently lacking… (More)
DOI: 10.1097/TP.0b013e31816f612a

Topics

3 Figures and Tables

Cite this paper

@article{Amico2008IncidenceAP, title={Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.}, author={Patrizia Amico and Gideon Hoenger and Denise Bielmann and Doris Lutz and Daniela Garzoni and J{\"{u}rg U Steiger and Michael J{\"{o}rg Mihatsch and Duska Dragun and S Schaub}, journal={Transplantation}, year={2008}, volume={85 11}, pages={1557-63} }